2.30
price down icon2.95%   -0.07
after-market アフターアワーズ: 2.76 0.46 +20.00%
loading

Conduit Pharmaceuticals Inc (CDT) 最新ニュース

pulisher
Jun 07, 2025

Conduit Pharmaceuticals (NASDAQ:CDT) Stock Price Down 0.4% – What’s Next? - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 - MENAFN.com

Jun 05, 2025
pulisher
Jun 04, 2025

Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 By Stocktwits - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

Conduit Pharmaceuticals enters joint development agreement with Manoira - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Conduit Pharma Expands Drug Pipeline to $15B Animal Health Market Through Zero-Cost Development Deal - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

Conduit Pharmaceuticals Sets 2025 Annual Meeting Date - TipRanks

Jun 03, 2025
pulisher
May 31, 2025

CDT stock plunges to 52-week low, hitting $3.21 amid steep decline By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

CDT stock plunges to 52-week low, hitting $3.21 amid steep decline - Investing.com India

May 30, 2025
pulisher
May 27, 2025

Conduit Pharmaceuticals regains Nasdaq compliance - MSN

May 27, 2025
pulisher
May 23, 2025

Conduit Pharmaceuticals receives approval for Nasdaq listing - MSN

May 23, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals approved to transfer listing to Nasdaq Capital Market - TipRanks

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals moves to Nasdaq Capital Market By Investing.com - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23 - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals moves to Nasdaq Capital Market - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals meets Nasdaq listing standards By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals meets Nasdaq listing standards - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Regains Compliance With Nasdaq's Bid Price, Equity Requirements - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Inc. Regains Compliance with Nasdaq Listing Requirements - Nasdaq

May 21, 2025
pulisher
May 19, 2025

Upcoming Stock Splits This Week (May 19 to May 23) – Stay Invested - The Globe and Mail

May 19, 2025
pulisher
May 17, 2025

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic - MSN

May 17, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals approves reverse stock split By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic By Stocktwits - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Announces Reverse Stock Split - TipRanks

May 16, 2025
pulisher
May 16, 2025

Barclays PLC Buys 54,523 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) - Defense World

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - The Manila Times

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals approves reverse stock split - Investing.com

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Inc. Announces 1-for-15 Reverse Stock Split Approval - Nasdaq

May 16, 2025
pulisher
May 15, 2025

CONDUIT PHARMACEUTICALS INC. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 15, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - The Manila Times

May 09, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Advancing Global Development Strategy for Autoimmune Disorders - Nasdaq

May 09, 2025
pulisher
May 08, 2025

Conduit Pharmaceuticals Files New Patent For AZD5904 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

In 2025, Will Conduit Pharmaceuticals Inc (NASDAQ: CDT) Be Bullish Or Bearish? - Stocksregister

May 08, 2025
pulisher
May 08, 2025

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - The Manila Times

May 08, 2025
pulisher
May 06, 2025

Conduit Pharmaceuticals Approves Reverse Stock Split Amendments - TipRanks

May 06, 2025
pulisher
May 06, 2025

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Shares Acquired by Geode Capital Management LLC - Defense World

May 06, 2025
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
大文字化:     |  ボリューム (24 時間):